Research To Practice | Oncology Videos

Dr Neil Love
undefined
Nov 21, 2026 • 55min

GPRC5D-Directed Therapies for Multiple Myeloma — An Interview with Prof Rakesh Popat

Featuring an interview with Prof Rakesh Popat, including the following topics: Overview of GPRC5D and its clinical significance (0:00) Key findings from Phase II TALisman study regarding dysgeusia assessment for patients receiving talquetamab (2:30) Mitigating dysgeusia and dry mouth arising from GPRC5D-directed therapy (6:25) Key findings from the Phase III MonumenTAL-3 study (11:49) Selection factors for GPRC5D- and BCMA-directed therapies (15:16) Managing extramedullary multiple myeloma (MM) with GPRC5D-targeted therapies and beyond (18:30) Key findings with arlocabtagene autoleucel (arlo-cel) for relapsed/refractory (R/R) MM (20:47) Ramantamig and other GPRC5D-targeted approaches (25:32) Comparing arlo-cel to ciltacabtagene autoleucel for MM; CNS issues with GPRC5D-directed therapies (28:42) Case: A man in his late 70s with a history of chronic obstructive pulmonary disease and t(4;14) R/R MM who receives fourth-line talquetamab and attains a very good partial response (38:27) Cases: A man in his late 40s with t(11;14), del(17p) R/R MM who enrolls in the Phase II QUINTESSENTIAL-2 study for third-line treatment; a man in his late 60s with t(11;14), del(17p) MM and early relapse after third-line autologous stem cell transplant (45:18) Guidance on sequencing BCMA- and GPRC5D-directed therapies (47:35) Importance of tumor debulking; access to arlo-cel (52:27) CME information and select publications
undefined
Nov 20, 2026 • 19min

GPRC5D-Directed Therapies for Multiple Myeloma — An Interview with Prof Rakesh Popat (Companion Faculty Lecture)

Featuring a slide presentation and related discussion from Prof Rakesh Popat, including the following topics: Overview of GPRC5D in multiple myeloma (0:00) Key findings from the Phase I/II MonumenTAL-1 clinical trial (2:01) Key findings from the Phase III MonumenTAL-3 trial (5:50) Key findings from a Phase I study of arlocabtagene autoleucel and Phase II QUINTESSENTIAL study; ongoing Phase III QUINTESSENTIAL-3 study (8:51) Key findings from the Phase Ib/II RedirecTT-1 and Phase III MonumenTAL-6 study (13:29) Other GPRC5D treatments in development (16:44) CME information and select publications
undefined
Nov 16, 2026 • 16min

Novel Therapies for Non-Hodgkin Lymphoma — Microlearning Activity 3: An Interview with Dr Matthew Lunning on The Utility of Tafasitamab

Featuring an interview with Dr Matthew Lunning, including the following topics: Tafasitamab for follicular lymphoma (0:00) frontMIND Phase III trial of tafasitamab/lenalidomide/R-CHOP for diffuse large B-cell lymphoma (7:51) CME information and select publications
undefined
Nov 14, 2026 • 58min

Follicular Lymphoma — Where We Are, Where We're Headed in the Use of Bispecific Antibodies

Matthew Matasar, a lymphoma specialist at Rutgers, and Chan Chea, a hematologist and clinical investigator in Perth, explore bispecific antibodies in follicular lymphoma. They discuss mechanisms, second-line treatment choices, sequencing with CAR-T, and real-world complications including cytokine release syndrome and infections. The conversation also spotlights surovatamig, first-line trials, multispecific antibodies, and emerging treatment targets.
undefined
Nov 13, 2026 • 27min

Follicular Lymphoma | Matthew Matasar, MD

Where We Are, Where We're Headed: Bispecific Antibodies in the Management of Follicular Lymphoma | Faculty Presentation 2: Emerging Bispecific Antibody Strategies for Follicular Lymphoma — Dr Matasar CME information and select publications
undefined
Nov 13, 2026 • 27min

Follicular Lymphoma | Professor Chan Cheah, MBBS (Hons), DMSc

Where We Are, Where We're Headed: Bispecific Antibodies in the Management of Follicular Lymphoma | Faculty Presentation 1: Current Use of Bispecific Antibodies for Relapsed/Refractory Follicular Lymphoma — Prof Cheah CME information and select publications
undefined
Nov 11, 2026 • 1h 2min

Relapsed/Refractory Multiple Myeloma — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute

Featuring perspectives from Dr Sagar Lonial and Dr Paul G Richardson, including the following topics: Multiple Myeloma (0:00) Introduction: ESMO 2026; Recent FDA Approvals (1:53) Chimeric Antigen Receptor T-Cell Therapy — Dr Lonial (2:46) Bispecific Antibodies — Dr Lonial (19:16) Antibody-Drug Conjugates — Dr Richardson (37:08) Up-Front Treatment; Cereblon E3 Ligase Modulators — Dr Richardson (50:10) CME information and select publications
undefined
Nov 10, 2026 • 59min

Prostate Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute

Featuring perspectives from Dr Neeraj Agarwal and Dr Emmanuel S Antonarakis, including the following topics: Introduction: ESMO 2026; Recent FDA Approvals (0:00) Selection of Endocrine Therapy — Dr Antonarakis (2:24) Utility of PARP Inhibitors — Dr Agarwal (22:59) AKT Inhibition for PTEN-Deficient Disease — Dr Antonarakis (35:42) Radiopharmaceuticals — Dr Agarwal (45:02) CME information and select publications
undefined
Nov 9, 2026 • 2h 22min

Breast Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute

Featuring perspectives from Dr Charles E Geyer Jr, Dr Maryam Lustberg, Dr Rita Nanda and Dr Seth Wander, including the following topics: Breast Cancer Introduction: ESMO 2026; Recent FDA Approvals (0:00) ER-Positive Breast Cancer (5:01) HER2-Positive Breast Cancer (1:19:08) Triple-Negative Breast Cancer (1:48:54) CME information and select publications
undefined
Nov 6, 2026 • 18min

Novel Therapies for Non-Hodgkin Lymphoma — Microlearning Activity 2: An Interview with Dr Matthew Lunning on Novel Combination Regimens

Featuring an interview with Dr Matthew Lunning, including the following topics: Bispecific antibody/antibody-drug conjugate combinations (0:00) A man in his late 90s with mantle cell lymphoma — Ann LaCasce, MD, MMSc (8:07) CME information and select publications

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app